Clinical Trial Update: Type 2 Diabetes Haptoglobin Phenotype and Vitamin E [Phase 2, Phase 3]

View source ↗

Summary

Completed Phase 2/Phase 3 trial investigating Vitamin E in patients with Type 2 diabetes mellitus, with analyses based on haptoglobin phenotype.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Vitamin E (tocopherol)

Snippet

Sponsor: Technion, Israel Institute of Technology | Conditions: Diabetes Mellitus Type 2 | Phase 2, Phase 3 | Status: COMPLETED